What question did this study set out to answer?

To evaluate HRCT Thorax manifestations of COVID-19 in cancer patients and identify atypical features.

A Retrospective Cross-sectional Study of High-Resolution Computed tomography Thorax Manifestations in Cancer Patients Suspected to Have Coronavirus Disease 2019 Infection

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cross-sectional study reveals diagnostic challenges of COVID-19 in cancer patients, impacting management decisions.

To evaluate HRCT Thorax manifestations of COVID-19 in cancer patients and identify atypical features.
Conducted a retrospective cross-sectional study at a tertiary care hospital between August 2020 and February 2021.
Included 100 cancer patients with suspected COVID-19 referred for HRCT Thorax.
Analyzed categorical and continuous variables with data visualization tools.
64% of patients were RT-PCR positive for COVID-19.
Main HRCT finding was ground-glass opacities (78%), with other atypical features identified.
CT severity score >8 indicated more severe disease and guided management.

Ghodke et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark